mifepristone | | |
Major use for this drug: treating endometriosis | | |
selective nonsteroidal aromatase inhibitor; approved for use in treating breast tumors | | |
used for treating ovulation disorders in patients wishing to become pregnant | | |
competitive partial agonist inhibitor of estradiol; used as an adjunct in treating breast cancer (especially estrogen-positive tumors) | | |
beneficial effect of oral contraceptive use: | | |
most important human progestin | | |
brain neurotransmitter | | |
most common adverse effect in patients treated with clomiphene: | | |
hormonal contraception by progestin implants (subcutaneous) | | |